AoE Flu Seminars 2008

Date TopicSpeaker
18 Dec 2008 Effect of alternative activation of macrophages on phagocytosis of pathogens and inflammatory response Dr Audrey Varin
Post-Doctoral Fellow
Sir William Dunn School of Pathology, Oxford University
10 Dec 2008 A family of Bcl-2 proteins from vaccinia virus that inhibit apoptosis and/or innate immune signaling Prof. Geoffrey L. Smith FRS
Department of Virology Imperial College London
17 Nov 2008 Viral and cellular forces that drive virion assembly: examples of SARS-CoV and H5N1 avian influenza viruses Dr. Beatrice Nal-Rogier
HKU-Pasteur Research Centre
The epidemiology of pandemic and non-pandemic influenza Dr. Steven Riley
Community Medicine, HKU
15 Oct 2008 Selective modulation of innate immunity and inflammation as a new strategy for treating infections Prof. Robert E.W. Hancock
Department of Microbiology and Immunology
University of British Columbia
15 Aug 2008 Antigenic profiling of avian H5N1 viruses and implication for pre-pandemic vaccine strain selection Dr. Chen Hong-lin
Microbiology, HKU
Epidemiology and control of influenza in the community Dr. Ben Cowling
Community Medicine, HKU
28 May 2008 Evolution of H5N1 avian influenza Dr. Gavin Smith
Microbiology, HKU
Generation of humanized mice and its application Dr. Wenwei Tu
Paediatrics, HKU
25 Apr 2008 Host molecular landscape during HIV-1 viral replication: depiction by quantitative proteomics Dr. Eric Y Chan
University of Washington, Seattle, U.S.A
25 Mar 2008 Interferon: a fight for supremacy in SARS and other emerging viral infections Dr. Eleanor N. Fish
University of Toronto
(Guest of John Nicholls, Pathology, HKU)
14 Mar 2008 Recent studies of SARS and human influenza Ben Cowling
Community Medicine, HKU
26 Feb 2008 Control of seasonal and pandemic influenza: interrelated challenges Prof. Arnold S. Monto
University of Michigan, U.S.A.
10 Jan 2008 H5N1 viruses: transmissibility, pathogenicity and antiviral treatment Dr. Yen Hui-Ling
St. Jude, Memphis, U.S.A.